Trial record 2 of 3 for:    cannabinoids | autism

Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03202303
Recruitment Status : Not yet recruiting
First Posted : June 28, 2017
Last Update Posted : November 14, 2018
United States Department of Defense
Information provided by (Responsible Party):
Eric Hollander, Montefiore Medical Center

No Study Results Posted on for this Study
  Recruitment Status : Not yet recruiting
  Estimated Primary Completion Date : June 30, 2021
  Estimated Study Completion Date : September 30, 2021